You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SMZL

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Splenic Marginal Zone Lymphoma Trial in Worldwide (Rituximab, Zanubrutinib)

Not yet recruiting
  • Splenic Marginal Zone Lymphoma
  • Aarhus, Denmark
  • +4 more
Feb 17, 2023

Marginal Zone Lymphoma, Nodal Marginal Zone Lymphoma, Splenic Marginal Zone Lymphoma Trial in Worldwide (Ibrutinib, Rituximab)

Recruiting
  • Marginal Zone Lymphoma
  • +2 more
  • Yvoir, Belgium
  • +36 more
Nov 4, 2022

Marginal Zone Lymphoma Trial (Mosunetuzumab + Lenalidomide, - Rituximab + Lenalidomide (28-days cycles, - Rituximab +

Not yet recruiting
  • Marginal Zone Lymphoma
  • Mosunetuzumab + Lenalidomide
  • +3 more
  • (no location specified)
Aug 16, 2023

Marginal Zone Lymphoma Trial in Austria, Italy, Switzerland (Tafasitamab, Acalabrutinib)

Recruiting
  • Marginal Zone Lymphoma
  • Wien, Austria
  • +9 more
Jul 13, 2022

Lymphoma, T-Cell, Cutaneous, Lymphoma, T-Cell, Peripheral, Chronic Lymphocytic Leukemia Trial in Ann Arbor (Pacritinib)

Terminated
  • Lymphoma, T-Cell, Cutaneous
  • +6 more
  • Ann Arbor, Michigan
    University of Michigan Rogel Cancer Center
Jan 20, 2021

Integrated Molecular and Clinical Profiling to Optimize Outcome

Completed
  • Splenic Marginal Zone Lymphoma
    • Bellinzona, Switzerland
      IOSI
    Jun 4, 2021

    Marginal Zone Lymphoma, B-cell Lymphoma Trial in Worldwide (ibrutinib)

    Completed
    Has Results
    • Marginal Zone Lymphoma
    • B-cell Lymphoma
    • Tucson, Arizona
    • +24 more
    Oct 8, 2019